XFOR
XFOR
NASDAQ · Biotechnology

X4 Pharmaceuticals Inc

$4.12
-0.16 (-3.74%)
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 8 89%
Hold 1 11%
Sell 0 0%
Price Target
Analyst Price Target +589.8% upside
Low Target $21.41
Average Target $28.42
High Target $38.37
Current Price $4.12
Current
$4.12
Target
$28.42
$21.41 $28.42 avg $38.37
Scenario Analysis
Bear Case
$21.41
419.7%
Low target
Base Case
$28.42
+589.8%
Avg target
Bull Case
$38.37
+831.3%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$11.47
-64.1% from high
52-Week Low
$1.35
+205.2% from low
Target vs 52W High
$28.42
+147.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +24.3%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -3.7%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -27.6%